However, since C3 deficiency almost completely abolishes the release of C5a and MAC, which are crucial for the physiological protection against pathogens, and thus exposes the patient to an increased risk of infections and related side effects, the role of C5a-mediated signalling in CIPN models should be further investigated with the aim to develop more targeted treatment. The gene discussed is C5AR1; the disease is infection.